Moreover, UTX-mutant MM cells exhibit increased sensitivity to EZH2 inhibition both in vitro and in vivo, which correlates with reduced levels of IRF4 and c-MYC, as well as the activation of IRF4 repressors specific to germinal center B cells, such as BCL6 and IRF1. Here, IRF4 is linked to Miyoshi myopathy.